Neuroimmunological adverse events associated with immune checkpoint inhibitor: a retrospective, pharmacovigilance study using FAERS database.

导出原文传递

翻译打印收藏纠错

作者： Takahisa,Mikami ^[1] ; Bobby,Liaw ^[2] ; Mizuho,Asada ^[3] ; Takahiro,Niimura ^[4] ; Yoshito,Zamami ^[5] ; Deborah,Green-LaRoche ^[5] ; Lori,Pai ^[6] ; Michael,Levy ^[7] ; Suriya,Jeyapalan ^[8]

作者单位： Department of Neurology, Tufts Medical Center, Boston, MA, USA. taka.mikami.tmd@gmail.com. ^[1] Department of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, Mount Sinai Beth Israel, New York, NY, USA. taka.mikami.tmd@gmail.com. ^[2] Department of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, Mount Sinai Beth Israel, New York, NY, USA. ^[3] Department of Pharmacy, Medical Hospital, Tokyo Medical and Dental University, Tokyo, Japan. ^[4] Department of Clinical Pharmacology and Therapeutics, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan. ^[5] Department of Pharmacy, Tokushima University Hospital, Tokushima, Japan. ^[6] Department of Neurology, Tufts Medical Center, Boston, MA, USA. ^[7] Department of Hematology and Oncology, Tufts Medical Center, Boston, MA, USA. ^[8] Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA. ^[9]

关键词 FAERS database Immune checkpoint inhibitors Neurologic adverse events